Cha BS - Search Results

1

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes.

Lee S, Bae J, Jo DR, Lee M, Lee YH, Kang ES, Cha BS, Lee BW. Lee S, et al. Among authors: cha bs. Front Endocrinol (Lausanne). 2023 Feb 22;14:1124576. doi: 10.3389/fendo.2023.1124576. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36896171 Free PMC article.

2

Targeting of therapeutic gene expression to the liver by using liver-type pyruvate kinase proximal promoter and the SV40 viral enhancer active in multiple cell types.

Park CW, Park YM, Lee GT, Lee Y, Woo S, Cha JY, Ahn CW, Cha BS, Kim KS, Ahn YH, Lee HC. Park CW, et al. Among authors: cha bs, cha jy. Biochem Biophys Res Commun. 2004 Jan 30;314(1):131-7. doi: 10.1016/j.bbrc.2003.12.064. Biochem Biophys Res Commun. 2004. PMID: 14715256

3

Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.

Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS. Kim HJ, et al. Among authors: cha bs. Arch Intern Med. 2004 Oct 25;164(19):2169-75. doi: 10.1001/archinte.164.19.2169. Arch Intern Med. 2004. PMID: 15505132

4

Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes.

Kang ES, Kim HJ, Kim YM, Lee S, Cha BS, Lim SK, Kim HJ, Lee HC. Kang ES, et al. Among authors: cha bs. Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S115-20. doi: 10.1016/j.diabres.2004.05.009. Diabetes Res Clin Pract. 2004. PMID: 15563960

5

Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats.

Park YM, Woo S, Lee GT, Ko JY, Lee Y, Zhao ZS, Kim HJ, Ahn CW, Cha BS, Kim KS, Park CW, Lee HC. Park YM, et al. Among authors: cha bs. J Gene Med. 2005 May;7(5):621-9. doi: 10.1002/jgm.708. J Gene Med. 2005. PMID: 15651056

6

Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea.

Kang ES, Yun YS, Park SW, Kim HJ, Ahn CW, Song YD, Cha BS, Lim SK, Kim KR, Lee HC. Kang ES, et al. Among authors: cha bs. Metabolism. 2005 Feb;54(2):206-11. doi: 10.1016/j.metabol.2004.08.014. Metabolism. 2005. PMID: 15690315 Clinical Trial.

7

Hypercalcemia in hepatic tuberculosis: a case report in Korea.

Kang ES, Do MY, Park SY, Hur KY, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC. Kang ES, et al. Among authors: cha bs. Am J Trop Med Hyg. 2005 Apr;72(4):368-9. Am J Trop Med Hyg. 2005. PMID: 15827271

8

The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes.

Kang ES, Park SY, Kim HJ, Ahn CW, Nam M, Cha BS, Lim SK, Kim KR, Lee HC. Kang ES, et al. Among authors: cha bs. Diabetes Care. 2005 May;28(5):1139-44. doi: 10.2337/diacare.28.5.1139. Diabetes Care. 2005. PMID: 15855579

9

Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes.

Kang ES, Kim HJ, Ahn CW, Park CW, Cha BS, Lim SK, Kim KR, Lee HC. Kang ES, et al. Among authors: cha bs. Diabetes Res Clin Pract. 2005 Aug;69(2):151-9. doi: 10.1016/j.diabres.2004.11.014. Epub 2005 Jan 12. Diabetes Res Clin Pract. 2005. PMID: 16005364

10

Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes.

Kang ES, Park SY, Kim HJ, Kim CS, Ahn CW, Cha BS, Lim SK, Nam CM, Lee HC. Kang ES, et al. Among authors: cha bs. Clin Pharmacol Ther. 2005 Aug;78(2):202-8. doi: 10.1016/j.clpt.2005.04.013. Clin Pharmacol Ther. 2005. PMID: 16084854 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters